Tag Archives: BDX

Becton Dickinson Announces Planned Spinoff of Biosciences & Diagnostics — Waters Deal via $17.5 B Reverse Morris Trust

By |
1 Comment

Becton, Dickinson and Company (BDX) is poised to spin off its Biosciences & Diagnostic Solutions business—then merge it with Waters Corporation(WAT) in a reverse Morris Trust transaction valuing the deal at approximately $17.5 billion (Becton, Dickinson and Company). 📊 Key Deal Metrics & Structure Metric Details 2025 Pro Forma Sales ~$6.5 B combined revenues 2025 Pro Forma Adjusted EBITDA ~$2.0 B… Read More »

A HART-felt Farewell: Harvard Bioscience Board Approves HART Spin

By |
0 Comment

Harvard Bioscience Inc’s (HBIO) board of directors approved the spinoff of its regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology. The spin is set to take place on November 1st with HBIO shareholders receiving 1 share of the new company for every 4 shares of HBIO owned. The new company will trade under the ticker ‘HART’ and a when… Read More »